Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
MINISTRY OF HEALTH has floated a tender for Acquisition of Oncological Medications. (Process: 25410.011034/2023-23). The project location is Brazil and the tender is closing on 01 Apr 2024. The tender notice number is 91018/2024, while the TOT Ref Number is 99072509. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Brazil
Summary : Acquisition of Oncological Medications. (Process: 25410.011034/2023-23)
Deadline : 01 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 99072509
Document Ref. No. : 91018/2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : MINISTRY OF HEALTH
Rua Marques de Pombal, 125 Centro - Centro - Rio de Janeiro (RJ)
Telephone: (0xx21) 32075517
Fax: (0xx21)
Brazil
Tender Details
Object: Electronic Auction - Acquisition of Oncological Medicines. (PROCESS: 25410.011034/2023-23)
UASG Code: 250052
Notice from: 03/19/2024 from 09:00 to 16:00
Proposal Delivery: from 03/19/2024 at 09 :00Hs
CETUXIMAB, CONCENTRATION 5 MG/ML, PHARMACEUTICAL FORM INJ SOLUTION19981d172c851bd4e8a1788d5726c2d3ETABLE
Quantity: 5340
ERLOTINIB, DOSAGE 150 MG
Quantity: 7900
GEFITINIB, CONCENTRATION 250 MG
Quantity: 11549
GOSERELLIN ACETATE, DOSAGE 10.80 MG, INJECTABLE SOLUTION INDICATION
Quantity: 4737
GOSERELIN ACETATE, DOSAGE 3.6 MG, INJECTABLE SOLUTION INDICATION
Quantity: 1022
LANREOTID19981d172c851bd4e8a1788d5726c2d3ACETATE, CONCENTRATION 120 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS PROLONGED RELEASE
Quantity: 1828
LEUPRORELIN ACETATE, CONCENTRATION 22.5 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 4674
LEU PRORRELLIN ACETATE, CONCENTRATION 3, 75 MG, FARM FORM19981d172c851bd4e8a1788d5726c2d3ACEUTICA LYOPHIL POWDER FOR INJECTABLE
Quantity: 750
OCTREOTIDE, ACETATE SALT COMPOSITION, CONCENTRATION 20 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM
Quantity: 2135
PANITUMOMAB, CONCENTRATION 20 MG/ ML, SHAPE PHARMACEUTICAL INJECTABLE SOLUTION
Quantity19981d172c851bd4e8a1788d5726c2d3and: 3521
PEMBROLIZUMABE, CONCENTRATION 25 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 1428
TRIPTORRELIN, COMPOSITION SALT EMBONATO, CONCENTRATION 11.25 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 1950
TRIPTORRE LINA, ACETATE SALT COMPOSITION, CONCENTRATION 3.75 MG/ML, FAR FORM19981d172c851bd4e8a1788d5726c2d3MACEUTICA INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS FILLED SYRINGE, PROLONGED RELEASE
Quantity: 750
TRIPTORRELIN, COMPOSITION SALT EMBONATO, CONCENTRATION 3.75 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 750
NIVOLUMAB, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM INJ SOLUTION19981d172c851bd4e8a1788d5726c2d3ETABLE
Quantity: 235
NIVOLUMAB, CONCENTRATION 10 MG/ML, FORM...
Documents
Want To Bid in This Tender?
Get Local Agent Support in Brazil and 60 More Countries.
View Tenders By
Sign in with Google